CaliPharms Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2013	FY 2012	FY 2012	FY 2011	FY 2010
Period Ending	Feb '26 Feb 11, 2026	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010
Market Capitalization	0	8	-	-	-	-
Enterprise Value	-	11	-	-	-	-
Last Close Price	0.00	0.00	-	-	-	-
PB Ratio	0.00	-3.39	-	-	-	-
Debt / Equity Ratio	-0.02	-0.28	-0.25	-0.70	-0.34	-0.34
Net Debt / Equity Ratio	-0.02	-0.28	-0.25	-0.70	-0.34	-0.34
Net Debt / EBITDA Ratio	-	-	-	-	-	-5.58
Net Debt / FCF Ratio	-0.28	-13.33	-569.93	-14.72	-35.27	-7.64
Quick Ratio	0.00	-	-	-	0	-
Current Ratio	0.00	-	-	-	0	0
Return on Assets (ROA)	-	-	-	-11.79%	-43.30%	-33.05%
Return on Capital Employed (ROCE)	8.80%	8.80%	33.10%	15.30%	8.60%	6.30%
Earnings Yield	-45485.85%	-2.63%	-	-	-	-
FCF Yield	-	-0.61%	-	-	-	-
Buyback Yield / Dilution	-31942.59%	-285.84%	-150.09%	-32.66%	-94.34%	-465.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.